Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines

In this study, we used patient-specific and isogenic PARK2-induced pluripotent stem cells (iPSCs) to show that mutations in PARK2 alter neuronal proliferation. The percentage of TH(+) neurons was decreased in Parkinson’s disease (PD) patient-derived neurons carrying various mutations in PARK2 compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaltouki, Atossa, Sivapatham, Renuka, Pei, Ying, Gerencser, Akos A., Momčilović, Olga, Rao, Mahendra S., Zeng, Xianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437475/
https://www.ncbi.nlm.nih.gov/pubmed/25843045
http://dx.doi.org/10.1016/j.stemcr.2015.02.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437475/
https://www.ncbi.nlm.nih.gov/pubmed/25843045
http://dx.doi.org/10.1016/j.stemcr.2015.02.019

Ejemplares similares